US Patent Issued to Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences on June 30 for "Construction method of recombinant drug-resistant Mycobacterium bovis bacillus calmette-guerin (BCG) strain and pharmaceutical composition for treating tuberculosis (TB)" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,608, issued on June 30, was assigned to Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (Guangzhou, China).

"Construction method of recombinant drug-resistant Mycobacterium bovis bacillus calmette-guerin (BCG) strain and pharmaceutical composition for treating tuberculosis (TB)" was invented by Tianyu Zhang (Guangzhou, China), Bangxing Wang (Guangzhou, China), Julius Ndirangu Mugweru (Guangzhou, China), Gift Chiwala (Guangzhou, China) and Zhiyong Liu (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a construction method of a recombinant drug-resistant Mycobacterium bovis (M. bovis) Bacillus C...